Lion's Mane, Yamabushitake · 2009 · Patent
Low relevanceUntitled study
Hericium erinaceus
Cognition & nervesLiver support
Key points
- A pharmaceutical composition for an improvement on Alzheimer's disease is provided to supply the pharmaceutical composition to a patient by oral inoculation without a side effect such as dizziness, vomiting, and hepatotoxicity
- A pharmaceutical composition for an improvement on Alzheimer's disease comprises 50~70wt% of lecithin powder, 25~42wt% of hericium erinaceus powder, 1~3wt% of sucrose fatty acid ester, 0.1~0.2wt% of folic acid, 0.2~1wt% of vitamin C, 0.2~1wt% of vitamin B, 0.2~1wt% of vitamin B2, 0.2~1wt% of HPMC, and 2~5wt% of lactose
From the paper
Abstract
A pharmaceutical composition for an improvement on Alzheimer's disease is provided to supply the pharmaceutical composition to a patient by oral inoculation without a side effect such as dizziness, vomiting, and hepatotoxicity. A pharmaceutical composition for an improvement on Alzheimer's disease comprises 50~70wt% of lecithin powder, 25~42wt% of hericium erinaceus powder, 1~3wt% of sucrose fatty acid ester, 0.1~0.2wt% of folic acid, 0.2~1wt% of vitamin C, 0.2~1wt% of vitamin B, 0.2~1wt% of vitamin B2, 0.2~1wt% of HPMC, and 2~5wt% of lactose.
Citation
JEON BYONG TAE, KIM SANG MIM (2009). Untitled study.
Open citation